ArticleCancer research2022

Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma.

Caitlin M O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.